Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein

The respiratory syncytial virus (RSV) causes significant respiratory disease in young infants and the elderly. Immune prophylaxis in infants is currently limited to palivizumab, an anti-RSV fusion (F) protein monoclonal antibody (mAb). While anti-F protein mAbs neutralize RSV, they are unable to pre...

Cijeli opis

Bibliografski detalji

Glavni autori:	Harrison C. Bergeron, Jackelyn Murray, Aakash Arora, Ana M. Nuñez Castrejon, Rebecca M. DuBois, Larry J. Anderson, Lawrence M. Kauvar, Ralph A. Tripp
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2023-04-01
Serija:	Viruses
Teme:	RSV G protein F protein mAb 3D3 2D10
Online pristup:	https://www.mdpi.com/1999-4915/15/5/1067
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!